Tech Company Financing Transactions
GlucoTec Funding Round
GlucoTec, operating out of Waltham, secured $8.3 million from Sea Dragon Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
9/27/2011
Transaction Type
Venture Equity
Amount
$8,273,078
Round
Series A
Investors
Sea Dragon Healthcare Partners (Lead Investor)
Proceeds Purpose
Glytec will use the capital primarily to expand its direct US sales force, increase its international presence and advance research and development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
460 Totten Pond Rd.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Glytec provides FDA-cleared insulin and glucose dosing software that replaces paper protocols for hospital based glycemic management. The software, called Glucommander 2.0 Enterprise Edition, provides individualized patient recommendations for intravenous and subcutaneous dosing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ed Furlong
VP - Bus. Development
John Downey
VP - Marketing
Joy Efron
VP - R & D
Robert Booth
VP - Regulatory Affairs
Raymie McFarland
Browse more venture capital transactions:
Prev: 9/27/2011: Spredfast venture capital transaction
Next: 9/27/2011: Clinipace venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs